Innate Pharma S.A. ADS (IPHA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Innate Pharma S.A. ADS, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$1.52
+2.70% today
Market cap
$165M
Overall quality
—
Kronos AI 30-day
+18.2%
8 of 8 simulated paths end higher
Innate Pharma S.A. ADS (IPHA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $165M. It trades at $1.52, up 2.70% today. 3 analysts' average target of $6.67 implies +338.8% from today's price. Kronos AI's 30-day forecast is +18.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $6.67 |
| Low – high | $4.00 – $9.00 |
| Analysts | 3 |
| Upside to average | +338.8% |
Kronos AI 30-day forecast
| Expected close | $1.75 (+18.2%) |
| Likely range | +14.5% … +29.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.